“As a neurologist and movement disorder specialist, I have seen many times how Parkinson’s disease affects the quality of life of patients and their families. I hope through my clinical contribution and research experience to have a significant impact in reducing their suffering and make a difference in their quality of life”
Dr. Strafella is a Krembil-Rossy Chair in Movement Disorders and Neuroimaging, Professor in the Dept. of Medicine (Division of Neurology) at the Toronto Western Hospital, University Health Network, University of Toronto. He is a Senior Scientist in the Krembil Brain Institute at the University Health Network, and a Scientist in the Brain Health Imaging Centre at CAMH (Centre for Addiction Mental Health). He is also a faculty member of the Institute of Medical Science at the University of Toronto.
Dr. Strafella is the Chair of the Neuroimaging Study Group of the International Parkinson and Movement Disorder Society and serves on the Board of Directors of the Canadian Academy of Health Sciences (CAHS).
The focus of his research is on Parkinson’s disease and atypical parkinsonism using advanced neuroimaging technology and novel PET radio-ligands. He is using a number of PET tracers and novel radio-ligands combined with MRI techniques to investigate the pathophysiology of motor, cognitive and behavioral symptoms in Parkinson’s disease and atypical parkinsonisms.
Dr. Strafella’s research studies have been funded by several granting agencies including CIHR, CFI, Parkinson Society Canada (now Parkinson Canada), National Parkinson Foundation-US, Parkinson Disease Foundation-US (now The Parkinson’s Foundation), Tourette Syndrome Association-US, E. J. Safra Foundation, and the Canada Research Chair Program.
Dr. Strafella serves on various scientific boards and a member of grant review panels at national (CIHR committees; Parkinson Canada) and international levels (Michael J. Fox Foundation, The Parkinson’s Foundation-USA; NIH and others).
